Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sjögren’s syndrome and rheumatoid arthritis

INTRODUCTION: Faecal calprotectin (FC) has been proposed to be a biomarker of gastrointestinal (GI) disease in systemic sclerosis (SSc). The purpose of this study was to extend cross-sectional observations and prospectively assess the variability of FC over time in SSc patients. We also aimed to exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Andréasson, Kristofer, Saxne, Tore, Scheja, Agneta, Bartosik, Izabela, Mandl, Thomas, Hesselstrand, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978565/
https://www.ncbi.nlm.nih.gov/pubmed/24499541
http://dx.doi.org/10.1186/ar4475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978565/
https://www.ncbi.nlm.nih.gov/pubmed/24499541
http://dx.doi.org/10.1186/ar4475

Ejemplares similares